Status:
UNKNOWN
mNGS vs Culture Critically Ill Patients
Lead Sponsor:
Southeast University, China
Collaborating Sponsors:
The First Affiliated Hospital with Nanjing Medical University
Northern Jiangsu People's Hospital
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
mNGS is popular in research and recently it has been used clinically to detect microbes in the blood or other secretion in infected patients for quicker ,broad and accurate detection of microbes. In I...
Detailed Description
Sepsis patients in ICU were took blood culture sample and blood sample for mNGS test (IDSeqTM Ultra, Combing with Metagenomics and Pathogen/AMR/VF Probe Enrichment). Clinicians use their knowledge and...
Eligibility Criteria
Inclusion
- Age \> 18years admit to ICU Meet the Sepsis 3.0 diagnostic criteria and suspected bloodstream infection, and the diagnosis of Sepsis ≤ 24 hours; Estimated ICU stay ≥ 24 hours; Informed consent;
Exclusion
- Severe organ dysfunction, expected death within 72 hours; Receive palliative care; Refuse to participate;
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT03760315
Start Date
April 1 2022
End Date
December 30 2022
Last Update
August 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing Zhong-Da Hospital
Nanjing, Jiangsu, China, 210009